|
Table of Contents
Terms Used In This Article
control group - in an
experiment a group which does not receive the treatment being investigated,
thus acting as a source of comparison for the experimental group
contusive - bruising
type injury
cystic cavity - fluid
filled cavity; contusive spinal cord injuries result in cystic cavities;
similar to a syrinx
hemopoietic stem cells (HSC)
- stem cells derived from blood
neural cells - cells
of the nervous system; the brain and spine
stem cells - cells
which have the ability to become other types of cells, such as muscle or
neural
white matter - type of
neural tissue
Common Chiari Terms
cerebellar tonsils -
portion of the cerebellum located at the bottom, so named because of their
shape
cerebellum - part of
the brain located at the bottom of the skull, near the opening to the spinal
area; important for muscle control, movement, and balance
cerebrospinal fluid (CSF) - clear liquid in the brain and spinal
cord, acts as a shock absorber
Chiari malformation I -
condition where the cerebellar tonsils are displaced out of the skull area
into the spinal area, causing compression of brain tissue and disruption of
CSF flow
decompression surgery -
general term used for any of several surgical techniques employed to
create more space around a Chiari malformation and to relieve compression
|
November 20, 2006 -- It seems like every week, or maybe even every
day, the headlines are announcing some new breakthrough involving stem
cells: Stem cells repair hearts! Stem cells repair spinal
injury! And of course each and every major media piece on stem cells
includes the obligatory phrase, "stem cells hold out the promise of curing
diabetes, heart disease, Alzheimer's, Parkinson's, and spinal cord injury".
Discerning the reality through the hype can be
difficult, especially given the inflamed rhetoric and ethical controversy
swirling around the use of embryonic stem cells. While the short-term
promise of stem cells may be exaggerated, and despite the hype, the reality
is that scientists are advancing our understanding of stem cells every day.
And with literally billions of research dollars ready to pour into the
field, researchers around the world are turning their attention to turning
the promise of stem cells into reality.
Why is this important to the Chiari community?
Because stem cells, which are able to become different types of cells, may
be one way to undo what is now permanent damage to the nervous system from syringomyelia. Neural cells, which make up the brain and
spinal cord, naturally do not regenerate very much. This is why damage
to the brain or nervous system, from an injury or disease, generally does
not heal well.
The biggest problem for people with Chiari and
syringomyelia after surgery is often the damage that occurred before there
was a diagnosis. The nerve damage can lead to intractable pain, loss
of function, and disability. Since nerve cells don't repair
themselves, stem cells - which can become new nerve cells - theoretically could
help repair the damage.
Given the focus which Christopher Reeve brought to the
issue of spinal cord injuries (SCI), many scientists are researching how
stem cells can be used to limit the damage from, or even repair, spinal
injuries. An example of their progress can be found in a report in the
November, 2006 issue of the Journal of Neurosurgery: Spine by a group from
Chiba University in Japan.
The Japanese researchers used stem cells derived from
umbilical cord blood to restore some functionality in spinal injured rats.
The group chose umbilical cord blood as a source of stem cells (these are
also known as homopoietic stem cells, or HSC) because of their wide
availability, ease of use, and because they avoid the ethical issues of
embryonic stem cells.
To study the effects of the stem cells, the
scientists used a well established model of spinal cord injury in rats where
a weight is dropped onto the exposed spine. Of interest to the Chiari
community is the fact that a crushing, or bruising injury like this results
in the formation of a cyst cavity at the site of the injury.
Nineteen rats were injured in this fashion and one week
later 8 of them were given an injection of the cord blood stem cells
directly into the center of the injury (the dura was opened for this).
The other 11 rats were given an injection of a control substance also in the
center of the injury.
Using a well established locomotion scale, the rats
were then assessed at various points in time after the injury and treatment.
On a motion scale ranging from 0-21, all rats scored a 21 prior to the
injury and scored a 0 immediately following the SCI (see Table 1).
However, at the five week point, the rats who were given the stem cells
scored an average of 9.8 versus only 7.2 for the control group. To
relate this to actual functionality, a score of 9.8 means the rats were able
to put some weight on their back legs, while a score of 7.2 means the rats
were not able to put any weight on their back legs.
To further examine the effects of the stem cells,
certain rats were euthanized at the different time points and their spinal
tissue examined microscopically. In this fashion, the researchers were
able to determine that the stem cell injections had actually significantly
reduced the size of the cystic cavity associated with the injury. In
other words, the stem cell rats had smaller cavities than the control rats.
Similarly, the rats who received the stem cells had more white matter - a
type of neural tissue - around the injury than the ones who didn't get the
treatment.
Interestingly, when the researchers looked for signs of
the injected stem cells in the spinal tissue they found that while the cells
were abundant one week after the treatment, they were largely gone by 3
weeks, and had completely disappeared by the 5 week mark. Also, and
somewhat of a surprise to the team, they could find no evidence that the
stem cells had actually become neural cells.
The Japanese study is a good example of the current
state of stem cell research, especially as it applies to spinal cord injury.
There are indications that stem cells can be of some benefit, but the gains
are not miraculous and scientists do not completely understand how they
work.
While it would seem the goal of completely
repairing nerve damage to the spine is a long way off, it is intriguing that
even at this early stage there are indications that stem cells reduced the
size of the cystic cavity. And given the incredible amount of
resources being applied to stem cell research, maybe the ability to repair
damage due to a syrinx will be here sooner rather than later.
-- Rick Labuda
Back to Table of Contents |
Key Points
-
The media is full of headlines
talking about the promise of stem cells
-
It can be difficult to assess what
stem cells can really do
-
Study used stem cells from umbilical
cord blood to study restoration of function in rats after spinal cord injury
-
Weight was dropped on the exposed
spines of rats to cause SCI
-
1 week after injury, stem cells were
injected into center of injury for some of the rats
-
Five weeks after injury, these rats
had noticeably improved function in hindlimbs versus control group
-
Stem cells also reduced the size of
the cystic cavity
-
Still a long way from stem cell type
treatments for SCI and syringomyelia
Table 1
Functional Restoration in Experimental Group vs Control Group (0-21)
| |
Experimental Group |
Control Group |
| Before SCI |
21 |
21 |
| After SCI |
0 |
0 |
| 5 wks After SCI |
9.8 |
7.2 |
Note: Standard Locomotion Scale was used with a max score of
21; rats were scored by two trained observers
Source: Nishio et al. The use of hemopoietic stem cells derived from
human umbilical cord blood to promote restoration of spinal cord tissue and
recovery of hindlimb function in adult rats J Neurosurg. 2006 Nov;105(5 Suppl):424-33.
Related C&S News Articles:
Rats Reveal Clues To The Damage That Syrinxes Cause
Review Of Post-Traumatic SM In England |